Synthetic vaccine derived from Plasmodium vivax circumsporozoite protein
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Synthetic vaccine derived from Plasmodium vivax circumsporozoite protein, covering 2021-03-01 to 2021-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of a Synthetic Vaccine Derived From Plasmodium Vivax Circumsporozoite Protein (PvCS) in naïve and Semi-immune Volunteers [Phase 2]